gecko47 has added a photo to the pool:
Flocks of these fruit-eaters gather in the canopies of fig and other fruit trees, often in the company of their relatives, the Olive-backed Orioles.
Plumage variable, depending on geographic distribution.
gecko47 has added a photo to the pool:
Male Superb Fairy-wren has some way to go before his plumage is as impressive as it should be. Possibly why he is hiding in the shadows!
りざーん has added a photo to the pool:
The rising sun lit the wild sea with a divine glow.
波立海岸/Hattachi Kaigan
Fukushima, Japan
りざーん has added a photo to the pool:
A quiet night under a billion stars.
野島崎/Nojimazaki
Chiba, Japan
JAKARTA (ANP) - Mensenrechtengroepen in Indonesië hebben hun bezorgdheid geuit over een terugkeer naar een autoritaire bestuursstijl onder president Prabowo Subianto, die sinds zes maanden aan de macht is.
Vorige maand besloot het parlement om militairen in actieve dienst toe te staan te werken in veertien overheidsinstellingen inclusief het Openbaar Ministerie. Mensenrechtengroepen vrezen dat dit de wettelijke controle op militair misbruik verzwakt. Voorheen konden militairen in tien overheidsinstellingen werken. Tegen deze uitbreiding zijn mensen de straat op gegaan. Ze willen dat de militairen terugkeren naar de kazernes.
Mensenrechtengroepen zijn bang dat Indonesië terugvalt in het systeem van dictator Suharto, die het land meer dan dertig jaar met ijzeren vuist regeerde. Onder Suharto was Prabowo commandant van een elite-eenheid die sociale onrust moest neerslaan.
Journalisten zeggen dat de persvrijheid onder Prabowo opnieuw wordt beknot.
BAD NAUHEIM (ANP) - In de Duitse plaats Bad Nauheim, even ten noorden van Frankfurt, zijn twee mannen doodgeschoten, zo maakte de politie zaterdag bekend.
De dader is gevlucht. De politie is een klopjacht begonnen.
Rond de plek waar de politie de doodgeschoten mannen aantrof werd een groot gebied afgezet voor onderzoek.
The founder/CEO of London-based LabGenius says their automated robotic system can assemble "thousands of different DNA constructs, each of which encodes a completely unique therapeutic molecule that we'll then test in the lab. This is something that historically would've had to have been done by hand." In short, CNN says, their system lets them "design and conduct experiments, and learn from them in a circular process that creates molecular antibodies at a rate far faster than a human researcher."
While many cancer treatments have debilitating side effects, CNN notes that LabGenius "reengineers therapeutic molecules so they can selectively target just the diseased cells."
But more importantly, their founder says they've now discovered "completely novel molecules with over 400x improvement in [cell] killing selectivity."
A senior lecturer at Imperial College London tells CNN that LabGenius seems to have created an efficient process with seamless connections, identifying a series of antibodies that look like they can target cancer cells very selectively "that's as good as any results I've ever seen for this." (Although the final proof will be what happens when they test them on patients..) "And that's the next step for Labgenius," says CNN. "They aim to have their first therapeutics entering clinics in 2027."
Finally, CNN asks, if it succeeds is their potential beyond cancer treatment? "If you take one step further," says the company's CEO/founder, "you could think about knocking out senescent cells or aging cells as a way to treat the underlying cause of aging."
Read more of this story at Slashdot.